S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +1.32%
Nvidia 221.97 +2.54%
Microsoft 532.95 +0.20%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7120 +0.15%
AFTER HRS · 19:25 ET
Market ClerkRecap
Wed Oct 21 · after hours2 signals today106 insider buys this week · $305.5MCIRO short report next: Oct 31The week ahead
YK
INSIDER · RAPP · Rapport Therapeutics, Inc. · CHIEF DEVELOPMENT OFFICER

Yeleswaram Krishnaswamy

Every open-market transaction filed under this name, Aug 19 to Aug 25.

Filings
4
0 buys · 4 sells
Bought
—
open market, at cost
Sold
$2.6M
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Aug 25RAPPRapport Therapeutics, Inc.Chief Development OfficerSell16,201$51.06$827K−44.5%
Aug 25RAPPRapport Therapeutics, Inc.Chief Development OfficerSell20,799$50.31$1M−43.7%
Aug 24RAPPRapport Therapeutics, Inc.Chief Development OfficerSell13,160$50.00$658K−43.3%
Aug 19RAPPRapport Therapeutics, Inc.Chief Development OfficerSell404$49.90$20K−43.2%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.